Kerrisdale Advisers’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-15,896
| Closed | -$127K | – | 52 |
|
|
2021
Q4 | $127K | Sell |
15,896
-437,286
| -96% | -$3.49M | 0.03% | 41 |
|
|
2021
Q3 | $3.79M | Hold |
453,182
| – | – | 0.41% | 36 |
|
|
2021
Q2 | $3.05M | Hold |
453,182
| – | – | 0.27% | 42 |
|
|
2021
Q1 | $3M | Hold |
453,182
| – | – | 0.23% | 44 |
|
|
2020
Q4 | $1.9M | Buy |
+453,182
| New | +$1.9M | 0.15% | 56 |
|
|
2020
Q3 | – | Sell |
-453,182
| Closed | -$2.76M | – | 68 |
|
|
2020
Q2 | $2.76M | Buy |
453,182
+5,525
| +1% | +$33.6K | 0.31% | 49 |
|
|
2020
Q1 | $2.46M | Sell |
447,657
-1,223
| -0.3% | -$6.72K | 0.47% | 39 |
|
|
2019
Q4 | $4.45M | Sell |
448,880
-16,700
| -4% | -$165K | 1.57% | 18 |
|
|
2019
Q3 | $2.68M | Hold |
465,580
| – | – | 1.68% | 16 |
|
|
2019
Q2 | $4.24M | Buy |
465,580
+401,900
| +631% | +$3.66M | 1.52% | 14 |
|
|
2019
Q1 | $883K | Buy |
+63,680
| New | +$883K | 0.17% | 20 |
|